# Advent Life Sciences Growth Fund LP — Form D/A

Advent Life Sciences Growth Fund LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2025-11-07. $9.8M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2025-11-07
- Form: D/A
- Accession: 0002040586-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $9.8M
- Investors: 1
- Date of first sale: 2024-10-14
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-527005

## Issuer

- Name: Advent Life Sciences Growth Fund LP
- CIK: 0002040586
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2023
- Address: 27 FITZROY SQUARE, LONDON, X0, W1T 6ES
- Phone: 44 020 7932 2120

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| - Advent Life Sciences LLP | Executive Officer | London, X0 |
| Kaasim Mahmood | Executive Officer | London, X0 |
| Shahzad Malik | Executive Officer | San Diego, CA |
| Rajesh Parekh | Executive Officer | London, X0 |
| Dominic Schmidt | Executive Officer | London, X0 |
| - Advent Life Sciences LLP | Promoter | London, X0 |
| Dominic Schmidt | Promoter | London, X0 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-10-17](https://search.stillhousedata.com/formd/0002040586-24-000001) | D | — | $9.8M |

## More

- [CIK 2040586 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2040586&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002040586-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.